US Broker Ratings

Kiniksa Pharmaceuticals (KNSA) Stock Analysis: Unveiling a 23.67% Upside with Robust Revenue Growth

Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA) is making waves in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. Based in the United..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: Unveiling a 24% Potential Upside in Biotech Innovation

Kymera Therapeutics, Inc. (NASDAQ: KYMR) is capturing investor attention with its innovative approach to biotechnology and a promising potential upside. As a clinical-stage biopharmaceutical company, Kymera..

Acadia Healthcare (ACHC) Stock Analysis: Evaluating its 12.32% Upside Potential Amidst Challenging Metrics

Acadia Healthcare Company, Inc. (NASDAQ: ACHC), a prominent player in the medical care facilities sector, is drawing significant attention from investors due to its recent stock..

Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a 32% Potential Upside for Investors

Surgery Partners, Inc. (NASDAQ: SGRY), a prominent player in the healthcare sector, is drawing attention with its potential for a 32.15% upside, according to recent analyst..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Exploring a 64.59% Potential Upside in the Biotechnology Sector

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) stands as a formidable player in the biotechnology sector, specializing in innovative treatments for neurological and rare diseases. With a market..

Zai Lab Limited (ZLAB) Stock Analysis: Biotech Giant Eyes 34.77% Potential Upside

Zai Lab Limited (NASDAQ: ZLAB), a leading player in the biopharmaceutical sector, is making waves with its promising growth potential, despite recent challenges in the biotech..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: Navigating a Stable Path with a $10.22 Billion Market Cap

Apogee Therapeutics, Inc. (NASDAQ: APGE), a dynamic player in the biotechnology sector, is making waves with its innovative approach to treating immunological and inflammatory diseases. Despite..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Unpacking a 13.4% Upside Potential

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) stands as a noteworthy player in the healthcare sector, specifically within the drug manufacturers – specialty and generic industry. With a..

Envista Holdings Corporation (NVST) Stock Report: Exploring a Potential 30% Upside

Envista Holdings Corporation (NYSE: NVST), a prominent player in the healthcare sector, specializes in medical instruments and supplies, focusing primarily on dental products. Headquartered in Brea,..

Veracyte, Inc. (VCYT) Stock Analysis: Unpacking a 32.70% Potential Upside in the Diagnostics Sector

Veracyte, Inc. (VCYT), a notable player in the healthcare sector, stands as a promising entity within the diagnostics and research industry. With a market capitalization of..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Exploring the 60.63% Potential Upside

For investors seeking opportunities in the biotechnology sector, PTC Therapeutics, Inc. (NASDAQ: PTCT) presents a compelling case with a robust potential upside of 60.63%, based on..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Potential 82% Upside with Strong Buy Ratings

Alignment Healthcare, Inc. (NYSE: ALHC) offers a compelling opportunity for investors seeking exposure to the fast-growing healthcare sector, particularly in the niche of senior-focused Medicare Advantage..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Evaluating Its 55% Potential Upside

Investors eyeing opportunities in the healthcare sector may want to take a closer look at DENTSPLY SIRONA Inc. (NASDAQ: XRAY). Despite recent challenges, the company presents..

Ultragenyx Pharmaceutical Inc. (RARE): Investor Outlook on a Promising 75% Potential Upside in Gene Therapy

For investors navigating the dynamic world of biotechnology, Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) presents a compelling case. With its focus on developing treatments for rare and..

Perrigo Company plc (PRGO) Stock Analysis: Navigating Healthcare with a 7.51% Dividend Yield

For individual investors eyeing a unique blend of stability and potential, Perrigo Company plc (PRGO) presents an intriguing opportunity in the healthcare sector. Headquartered in Dublin,..

BrightSpring Health Services (BTSG) Stock Analysis: Strong Buy Ratings Highlight 23.85% Upside Potential

BrightSpring Health Services, Inc. (NASDAQ: BTSG) has garnered significant attention in the healthcare sector, particularly due to its robust market presence and promising financial metrics. Founded..

Alkermes plc (ALKS) Stock Analysis: Exploring a 38.58% Potential Upside in Healthcare Innovation

Alkermes plc (NASDAQ: ALKS) stands at the forefront of the biopharmaceutical industry, leveraging its robust portfolio of proprietary products to address complex medical needs. With a..

Oscar Health, Inc. (OSCR) Stock Analysis: A Healthcare Tech Pioneer with 6% Upside Potential

Oscar Health, Inc. (NYSE: OSCR) stands at the crossroads of healthcare and technology, offering a compelling investment opportunity for those looking to capitalize on the rapidly..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: A Biotech Contender with 52.99% Upside Potential

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is making waves in the biotechnology sector with its promising focus on rare neuroendocrine diseases. Based in Boston, Massachusetts, this commercial-stage..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: A Potential 40% Upside Awaits Investors

Prestige Consumer Healthcare Inc. (NYSE: PBH), a leader in the over-the-counter (OTC) health and personal care sector, presents an intriguing opportunity for investors seeking value in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds